Oximation of the dihydroquinopimaric acid O-cyanoethylderivative (2) via the amidoxime 3, and cyclization with trifluoroacetic anhydride resulted in a new 1,2,4-oxadiazole diterpenoid (4).
KhatikGL, KaurJ, KumarV, TikooK, NairVA (2012) 1,2,4-Oxadiazoles: A new class of anti-prostate cancer agents. Bioorganic Medicinal Chemistry Letters, 22, 1912–1916.
7.
KumarD, PatelG, JohnsonEO, ShahK. (2009) Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles. Bioorganic Medicinal Chemistry Letters, 19, 2739–2741.
8.
IspikoudiM, AmvrazisM, KontogiorgisC, KoumbisAE, LitinasKE, Hadjipavlou-LitinaD, FylaktakidouKC. (2010) Convenient synthesis and biological profile of 5-amino-substituted 1,2,4-oxadiazole derivatives. European Journal of Medicinal Chemistry, 45, 5635–5645.
9.
dos Santos FilhoJM, LeiteACL, de OliveiraBG, MoreiraDRM, LimaMS, SoaresMBP, LeiteLFCC. (2009) Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosomacruzi agents. Bioorganic Medicinal Chemistry, 17, 6682–6691.
10.
MasahiroO, MamoruH, HideoS, MorioN. (2008) Development of novel beta-amyloid probes based on 3,5-diphenyl-1,2,4-oxadiazole. Bioorganic Medicinal Chemistry, 17, 6867–6672.
11.
HerzW, BlackstoneRC, NairMG. (1967) Resin acids. XI. Configuration and transformations of the levopimaric acid-p-benzoquinone adduct. Journal of Organic Chemistry, 32, 2992–2998.
12.
SmirnovaIE, Tret'yakovaEV, KazakovaOB, SuponitskyKY. (2010) Molecular structure of methyl 20-isopropyl-15(e)-hydroxyimino-5,9-dimethyl-18-oxahexacyclo[12.4.0.2 2,13.118,20.0 5,10.04,13]heneicosane-9-carboxylate. Journal of Structural Chemistry, 51, 1208–1210.
